Finance

Lists
Why is MEDS up 2.67%?
Dive Deeper
MEDS:IDX
Hetzer Medical Indonesia Tbk PT
IDR 77.00
+2.67%
(+2.00) 1D
Oct 14, 4:14:04 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for MEDS...
Open
IDR 75
High
IDR 79
Low
IDR 74
Mkt. cap
120.31B
Avg. vol.
164.43M
Volume
37.82M
52-wk high
IDR 157
52-wk low
IDR 53
EPS
-IDR 3
Shares outstanding
1.56B
No. of employees
18
Open
IDR 75
High
IDR 79
Low
IDR 74
Mkt. cap
120.31B
Avg. vol.
164.43M
Volume
37.82M
52-wk high
IDR 157
52-wk low
IDR 53
EPS
-IDR 3
Shares outstanding
1.56B
No. of employees
18
News stories
From web sources and news partners
About Hetzer Medical Indonesia Tbk PT
CEO-
Employees18
Founded2010
HeadquartersCimahi, West Java, Indonesia
SectorMedical device
Websiteevoplusmed.com
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.80B
1.68B
4.77B
6.77B
Cost of goods sold
1.65B
1.65B
3.13B
3.85B
Cost of revenue
1.65B
1.65B
3.13B
3.85B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.92B
2.80B
1.99B
2.04B
Operating expense
1.92B
2.80B
1.99B
2.04B
Total operating expenses
3.57B
4.46B
5.12B
5.89B
Operating income
-1.77B
-2.78B
-351.18M
874.64M
Other non operating income
81.81M
-103.24M
838.12M
-698.03M
EBT including unusual items
-1.85B
-2.85B
324.60M
-3.90M
EBT excluding unusual items
-1.85B
-2.85B
324.60M
-3.90M
Income tax expense
-
-221.90M
-
-
Effective tax rate
-
7.79%
-
-
Other operating expenses
-
-
-
-
Net income
-1.85B
-2.62B
324.60M
-3.90M
Net profit margin
-102.91%
-156.46%
6.81%
-0.06%
Earnings per share
-
-
-
-
Interest and investment income
391.52K
252.71M
383.73K
293.06K
Interest expense
-164.23M
-218.30M
-162.73M
-180.81M
Net interest expenses
-163.84M
34.42M
-162.34M
-180.51M
Depreciation and amortization charges
-
-
-
-
EBITDA
-463.79M
-2.15B
673.67M
1.88B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps